Meglumine: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
 
Line 17: Line 17:
[[Category:Medical imaging]]
[[Category:Medical imaging]]
{{medicine-stub}}
{{medicine-stub}}
<gallery>
File:Meglumine.svg|Meglumine
</gallery>

Latest revision as of 21:10, 23 February 2025

Meglumine, also known as N-methylglucamine, is a chemical compound commonly used in the pharmaceutical industry for its properties as a counterion. It is a derivative of glucose and is often used as a salt-forming agent in various medications. Meglumine is a colorless, odorless, and water-soluble compound that plays a crucial role in the formulation of certain drugs.

Chemical Properties[edit]

Meglumine has a molecular formula of C7H17NO5 and a molecular weight of 195.21 g/mol. It is classified as an amino sugar due to its structural similarity to glucose. The compound is highly polar and forms stable complexes with various acidic compounds, making it a valuable ingredient in pharmaceutical formulations.

Medical Uses[edit]

Meglumine is commonly used in the medical field as a component of contrast agents for diagnostic imaging procedures such as CT scans and MRI scans. It is particularly useful in enhancing the visibility of blood vessels and organs in medical imaging. Additionally, meglumine is utilized in certain medications to improve the solubility and stability of active pharmaceutical ingredients.

Side Effects[edit]

While meglumine is generally considered safe for medical use, some individuals may experience allergic reactions or hypersensitivity to the compound. Common side effects may include skin rashes, itching, or swelling at the injection site when used in contrast agents. In rare cases, more severe allergic reactions such as anaphylaxis may occur.

Precautions[edit]

Patients with a history of allergies to meglumine or related compounds should inform their healthcare providers before undergoing procedures or taking medications containing meglumine. Healthcare professionals should closely monitor patients for any signs of adverse reactions during and after the administration of meglumine-based products.

Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!